Now showing items 1-1 of 1
Comparison of renal toxicities with LY231514 600mg/m² versus 500mg/m² in the treatment of stage III or -IV cervical cancer
(Potchefstroom University for Christian Higher Education, 1999)
Cervical cancer is the most common cancer diagnosed in females in South Africa and constitutes 16.47% of all cancers registered. LY231514, a new multi-targeted antifolate, is a potent in vitro inhibitor of thyrnidylate ...